Treatment Planning & Management Flashcards

Which ethical principle is most at risk when a treatment plan is developed without meaningful patient input or shared decision-making?

Answer: Autonomy

Autonomy requires that patients have meaningful input into their care decisions; plans developed without patient involvement violate this foundational bioethical principle.

A healthcare organization uses predictive analytics to flag patients at high risk for treatment non-adherence. Integrating this risk score into treatment planning primarily supports:

Answer: Proactive personalization of interventions to improve adherence

Risk-stratified predictive scores enable care teams to personalize treatment plans with targeted adherence supports before non-adherence occurs, improving outcomes.

When a physician updates a treatment plan following an adverse drug event, which documentation practice is most important for medicolegal protection?

Answer: Documenting the event, clinical reasoning for the change, and new plan with timestamp

A contemporaneous, timestamped entry documenting the adverse event, clinical rationale, and updated plan creates a defensible legal and clinical record.

In population health management, treatment plans for high-risk patients are often stratified using which tool to prioritize resource allocation?

Answer: The Charlson Comorbidity Index or similar risk stratification model

Tools like the Charlson Comorbidity Index quantify disease burden and mortality risk, enabling analysts and care managers to prioritize high-risk patients for intensive treatment planning.

A healthcare analyst comparing treatment plan outcomes across demographically different patient populations should adjust for which variable to ensure valid comparisons?

Answer: Case mix and social determinants of health

Case mix and social determinants of health (SDOH) affect outcomes independently of treatment quality, so they must be controlled for in cross-population comparisons.

Which scenario would most likely trigger a mandatory plan-of-care revision under Joint Commission standards?

Answer: A significant change in the patient's clinical condition or response to treatment

Joint Commission standards require that treatment plans be reassessed and revised when there is a significant change in the patient's clinical status or when goals are not being met.

From a health economics perspective, what is the primary rationale for developing disease-specific treatment plan protocols (clinical pathways)?

Answer: To reduce unnecessary resource utilization while maintaining quality outcomes

Clinical pathways standardize evidence-based care to eliminate waste and unnecessary variation, thereby reducing costs without sacrificing clinical quality.